Hyderabad, June 13, 2016 - Tech Mahindra Limited, a leading provider of IT, Networks & Engineering solutions and BPO services and ArisGlobal®, a leading provider of cloud-based software solutions for life sciences, have partnered to provide the life sciences industry with a complete end-to-end solution that will not only address the regulatory compliance requirement IDMP (Identification of Medicinal Products) brings, but also provide a solution which will enable companies to ensure compliance, improve efficiencies and assure the safety of their products.
Wim Cypers, Senior Vice President at ArisGlobal stated “Life science companies currently focus on the upcoming EMA SPOR and future regulatory initiative but they also realize this is essential step but it is not the end goal for IDMP. It is clear that IDMP will impact other regulatory areas, not in the least in the area of patient safety and benefit/risk management. This partnership not only unites the regulatory and MDM expertise of both companies but also leverages our vast experience in other domains that will be impacted by IDMP. “
The solution provides both the technology as well as experience needed to provide companies with a clear path towards compliance and beyond. The IDMP solution helps companies to assess, collect and verify the information needed to achieve compliance through an application.
Venugopal Kandimalla, Global Head, Healthcare Life-Sciences Vertical – Tech Mahindra, commented “This engagement marks the coming together of two pioneering organisations and our alliance with ArisGlobal fosters mutual growth in regulatory space.”. This joint solution comprising of Master Data Management and regulatory interfacing application caters to EMA-IDMP compliance requirements of pharmaceutical companies.”
For Further Queries
Rajat Mittra | Global Media Relations | RM00461765@TechMahindra.com
ArisGlobal’s (www.arisglobal.com) innovative cloud-based solutions facilitate global drug development and regulatory compliance within the Life Sciences and Healthcare industries. Its cloud platform supports the entire product life cycle including Clinical Development, Regulatory Affairs, Pharmacovigilance and Medical Communications. Hundreds of drug and device manufacturers, CROs and regulatory agencies leverage ArisGlobal®’s advanced technology solutions to make better and more informed decisions, facilitate compliance, reduce risk and improve operational efficiency. Headquartered in the United States, ArisGlobal® has regional offices in Europe, India and Japan.
For Further Queries
Nicole Drapeau Gillen
Head of Marketing
Certain statements in this release concerning the future prospects of Tech Mahindra Limited (“the Company” or “TechM”) are forward-looking statements. These statements by their nature involve risks and uncertainties that could cause Company’s actual results differ materially from such forward looking statements. The Company, from time to time, makes written and oral forward-looking statements based on information available with the management of the Company and the Company does not undertake to update any forward-looking statement that may be made from time to time by or on behalf of the Company.